Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population ‐based cohort study

In conclusion, both metformin medication and TCM use could be associated with reduced risk of prostate cancer for men with BPH and diabetes.

Source: Cancer Medicine - April 8, 2019 Category: Cancer & Oncology Authors: Yu ‐Jui Kuo, Fung‐Chang Sung, Po‐Fan Hsieh, Hui‐Ping Chang, Kun‐Ling Wu, Hsi‐Chin Wu Tags: ORIGINAL RESEARCH Source Type: research